Oragenics (OGEN) Non Operating Income (2011 - 2026)

Oragenics (OGEN) has reported Non Operating Income for 16 consecutive years, with $17444.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Income rose 103.13% year-over-year to $17444.0; the trailing twelve-month figure through Jun 2026 stood at $181208.0 (up 123.6% YoY), and the FY2025 full-year result was -$616894.0, down 6676.82% from the prior year.
• Non Operating Income retreated to $17444.0 in Q2 2026 per OGEN's latest filing, from $32059.0 in the prior quarter.
• Across five years, Non Operating Income topped out at $81561.0 in Q3 2023 and bottomed at -$557833.0 in Q2 2025.
• Historically, Non Operating Income has averaged -$10857.6 across 5 years, with a median of $25596.5 in 2022.
• The widest YoY moves for Non Operating Income: up 1081.19% in 2025, down 61400.33% in 2025.
• Over 5 years, Non Operating Income stood at $61427.0 in 2022, then decreased by 20.4% to $48895.0 in 2023, then tumbled by 87.1% to $6309.0 in 2024, then jumped by 1081.19% to $74521.0 in 2025, then slumped by 76.59% to $17444.0 in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered $17444.0, $32059.0, and $74521.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.